Although loss of TβRII correlates with poor prognosis in esophageal cancer [328] and renal carcinoma [329], it also correlates with better survival rate in colon cancer [330] and gastric cancer [331], clearly indicating that the role of TβRII in carcinogenesis may be stage and tissue specific. Here, TGFBR2 is linked to gastric cancer.